6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ịdị ọcha>98.0% (LCMS) Ensitrelvir (S-217622) Oyiyi egosipụtara n'etiti COVID-19

6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ịdị ọcha>98.0% (LCMS) Ensitrelvir (S-217622) Ọkara COVID-19

Nkọwa dị mkpirikpi:

Aha: 6-Chloro-2-methyl-2H-indazol-5-amine

OZI: 1893125-36-4

Ọdị ọcha:>98.0% (LCMS)

Ọdịdị: Light Brown ka Grey Solid Powder

Ọkara nke Ensitrelvir (S-217622), COVID-19

Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ahịa Ensitrelvir (S-217622) Ndị etiti:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3- (Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4 (1H,3H) -dione, 3- (1,1-dimethylethyl) -6- (ethylthio) - CAS 1360105-53-8

Njirimara kemịkalụ:

Aha Chemical	6-Chloro-2-methyl-2H-indazol-5-amine
Nọmba CAS	1893125-36-4
Nọmba CAT	RF-PI1506
Ọnọdụ Ahịa	Dị na ngwaahịa
Usoro ihe omimi	C8H8ClN3
Ibu molekụla	181.62
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Agba aja aja ruo ntụ ntụ siri ike
Ụzọ ịdị ọcha / nyocha	> 98.0% (LCMS)
1 H NMR Spectrum	Nkwekọrịta na Ọdịdị
LCMS	Nkwekọrịta na Ọdịdị
Ọnwụ na ihicha	≤1.00%
Mgbakọta adịghị ọcha	<2.00%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Ensitrelvir (S-217622), COVID-19

Ngwungwu & Nchekwa:

ngwugwu: Kalama, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

Ajụjụ:

Ngwa:

6-Chloro-2-methyl-2H-indazol-5-amine (CAS: 1893125-36-4) bụ etiti nke Ensitrelvir (S-217622).Ensitrelvir nke Shionogi & Co. bụ ọgwụ mgbochi nje na-arụ ọrụ nke ọma yana Pfizer's Paxlovid.Oral Xocova (Ensitrelvir), nke nwere otu usoro ihe omume dị ka Pfizer's Paxlovid (Nirmatrelvir + Ritonavir), dị iche na ọ dị mkpa ka e were ya otu ugboro n'ụbọchị, ebe ọgwụgwọ ọgwụgwọ ensitrelvir adịghị ka ọ dị ala karịa Paxlovid.Dị ka ihe ncheta, a na-enye Nirmatrelvir ugboro abụọ kwa ụbọchị, yana ihe nkwalite nke Ritonavir nọchitere anya ya.Ensitrelvir ghọrọ ọgwụ mgbochi ụlọ mbụ nke Japan na-agwọ COVID-19, nke atọ ka akwadoro ya na Japan;na February 2022.